世界のコンパニオン診断市場2020-2024:ライフサイエンス、医療センター、その他

Technavioが発行した調査報告書(IRTNTR46416)
◆英語タイトル:Global Companion Diagnostics Market 2020-2024
◆商品コード:IRTNTR46416
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年12月23日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

テクナビオ社の本調査レポートでは、世界のコンパニオン診断市場について調査し、エグゼクティブサマリー、市場状況、市場規模、エンドユーザー別(ライフサイエンス、医療センター、その他)分析、顧客状況、地域別状況、企業状況、企業分析などを掲載しております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のコンパニオン診断市場規模:エンドユーザー別(ライフサイエンス、医療センター、その他)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Companion Diagnostics Market 2020-2024
Technavio has been monitoring the companion diagnostics market and it is poised to grow by $ 5.74 bn during 2020-2024 progressing at a CAGR of 26% during the forecast period. Our report on companion diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising use of personalized medicine, increased industry collaborations, and growing investments in life sciences sector. In addition, rising use of personalized medicine is anticipated to boost the growth of the market as well.
The companion diagnostics market analysis includes end-user segment and geographical landscapes.

Technavio’s companion diagnostics market is segmented as below:
By End-user
• Life science
• Health centers
• Others

By Geographic Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the rising occurrence of breast cancer as one of the prime reasons driving the companion diagnostics market growth during the next few years. Also, increase in product approvals to treat cancer and growing importance for promotional activities will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on companion diagnostics market covers the following areas:
• Companion diagnostics market sizing
• Companion diagnostics market forecast
• Companion diagnostics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc. Also, the companion diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/companion-diagnostics-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Life science – Market size and forecast 2019-2024
o Health centers – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by End-user
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume drivers – Demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Agilent Technologies Inc.
o bioMérieux SA
o F. Hoffmann-La Roche Ltd.
o Illumina Inc.
o Myriad Genetics Inc.
o QIAGEN NV
o Siemens Healthineers AG
o Sysmex Corp.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: End user – Market share 2019-2024 (%)
• 22: Comparison by End user
• 23: Life science – Market size and forecast 2019-2024 ($ million)
• 24: Life science – Year-over-year growth 2019-2024 (%)
• 25: Health centers – Market size and forecast 2019-2024 ($ million)
• 26: Health centers – Year-over-year growth 2019-2024 (%)
• 27: Others – Market size and forecast 2019-2024 ($ million)
• 28: Others – Year-over-year growth 2019-2024 (%)
• 29: Market opportunity by End user
• 30: Customer landscape
• 31: Market share by geography 2019-2024 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2019-2024 ($ million)
• 34: North America – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ million)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: Asia – Market size and forecast 2019-2024 ($ million)
• 38: Asia – Year-over-year growth 2019-2024 (%)
• 39: ROW – Market size and forecast 2019-2024 ($ million)
• 40: ROW – Year-over-year growth 2019-2024 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Abbott Laboratories – Overview
• 50: Abbott Laboratories – Business segments
• 51: Abbott Laboratories – Key offerings
• 52: Abbott Laboratories – Key customers
• 53: Abbott Laboratories – Segment focus
• 54: Agilent Technologies Inc. – Overview
• 55: Agilent Technologies Inc. – Business segments
• 56: Agilent Technologies Inc. – Key offerings
• 57: Agilent Technologies Inc. – Key customers
• 58: Agilent Technologies Inc. – Segment focus
• 59: bioMérieux SA – Overview
• 60: bioMérieux SA – Business segments
• 61: bioMérieux SA – Key offerings
• 62: bioMérieux SA – Key customers
• 63: bioMérieux SA – Segment focus
• 64: F. Hoffmann-La Roche Ltd. – Overview
• 65: F. Hoffmann-La Roche Ltd. – Business segments
• 66: F. Hoffmann-La Roche Ltd. – Key offerings
• 67: F. Hoffmann-La Roche Ltd. – Key customers
• 68: F. Hoffmann-La Roche Ltd. – Segment focus
• 69: Illumina Inc. – Overview
• 70: Illumina Inc. – Product and service
• 71: Illumina Inc. – Key offerings
• 72: Illumina Inc. – Key customers
• 73: Illumina Inc. – Segment focus
• 74: Myriad Genetics Inc. – Overview
• 75: Myriad Genetics Inc. – Business segments
• 76: Myriad Genetics Inc. – Key offerings
• 77: Myriad Genetics Inc. – Key customers
• 78: Myriad Genetics Inc. – Segment focus
• 79: QIAGEN NV – Overview
• 80: QIAGEN NV – Business segments
• 81: QIAGEN NV – Key offerings
• 82: QIAGEN NV – Key customers
• 83: QIAGEN NV – Segment focus
• 84: Siemens Healthineers AG – Overview
• 85: Siemens Healthineers AG – Business segments
• 86: Siemens Healthineers AG – Key offerings
• 87: Siemens Healthineers AG – Key customers
• 88: Siemens Healthineers AG – Segment focus
• 89: Sysmex Corp. – Overview
• 90: Sysmex Corp. – Product and service
• 91: Sysmex Corp. – Key offerings
• 92: Sysmex Corp. – Key customers
• 93: Sysmex Corp. – Segment focus
• 94: Thermo Fisher Scientific Inc. – Overview
• 95: Thermo Fisher Scientific Inc. – Business segments
• 96: Thermo Fisher Scientific Inc. – Key offerings
• 97: Thermo Fisher Scientific Inc. – Key customers
• 98: Thermo Fisher Scientific Inc. – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations



【掲載企業】

Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc.

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のコンパニオン診断市場2020-2024:ライフサイエンス、医療センター、その他(Global Companion Diagnostics Market 2020-2024)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆